Dashenlin Pharm Grp Co Ltd (603233) — Tangible Net Worth Ratio
Dashenlin Pharm Grp Co Ltd (603233) has a Tangible Net Worth Ratio of 78.5% as of March 2026. This metric is calculated by deducting intangible assets (CN¥1.98 Billion) from net assets (CN¥9.18 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See shareholders equity of Dashenlin Pharm Grp Co Ltd for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Dashenlin Pharm Grp Co Ltd Tangible Net Worth Ratio (2012–2025)
This chart shows how Dashenlin Pharm Grp Co Ltd's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 78.5%, reflecting net assets of CN¥9.18 Billion with intangible assets of CN¥1.98 Billion CNY. Also explore Dashenlin Pharm Grp Co Ltd (603233) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Dashenlin Pharm Grp Co Ltd (2012–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Dashenlin Pharm Grp Co Ltd from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 603233 stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 77.0% | CN¥8.66 Billion | CN¥1.99 Billion | CN¥26.49 Billion | ▲ +1.5 pp |
| 2024 | 75.5% | CN¥8.14 Billion | CN¥1.99 Billion | CN¥26.44 Billion | ▼ -0.8 pp |
| 2023 | 76.3% | CN¥7.93 Billion | CN¥1.88 Billion | CN¥24.12 Billion | ▼ -13.5 pp |
| 2022 | 89.8% | CN¥6.86 Billion | CN¥700.55 Million | CN¥20.84 Billion | ▲ +1.2 pp |
| 2021 | 88.6% | CN¥5.94 Billion | CN¥676.41 Million | CN¥17.34 Billion | ▼ -1.7 pp |
| 2020 | 90.3% | CN¥5.57 Billion | CN¥538.53 Million | CN¥12.33 Billion | ▼ -0.8 pp |
| 2019 | 91.1% | CN¥4.33 Billion | CN¥384.83 Million | CN¥8.67 Billion | ▲ +0.4 pp |
| 2018 | 90.7% | CN¥3.09 Billion | CN¥287.63 Million | CN¥6.54 Billion | ▼ -5.2 pp |
| 2017 | 95.9% | CN¥2.80 Billion | CN¥114.12 Million | CN¥5.82 Billion | ▲ +0.9 pp |
| 2016 | 95.0% | CN¥1.34 Billion | CN¥67.10 Million | CN¥3.58 Billion | ▲ +1.3 pp |
| 2015 | 93.7% | CN¥1.02 Billion | CN¥63.85 Million | CN¥2.66 Billion | ▲ +2.4 pp |
| 2014 | 91.3% | CN¥574.85 Million | CN¥49.99 Million | CN¥2.37 Billion | ▼ -1.7 pp |
| 2013 | 93.0% | CN¥589.93 Million | CN¥41.08 Million | CN¥1.68 Billion | ▲ +2.2 pp |
| 2012 | 90.8% | CN¥381.11 Million | CN¥34.93 Million | CN¥996.51 Million | — |